Home/Filings/4/0001192482-11-000123
4//SEC Filing

Rogers Michael D. 4

Accession 0001192482-11-000123

CIK 0001301081other

Filed

May 10, 8:00 PM ET

Accepted

May 11, 4:32 PM ET

Size

8.5 KB

Accession

0001192482-11-000123

Insider Transaction Report

Form 4
Period: 2011-05-09
Rogers Michael D.
Chief Development Officer
Transactions
  • Exercise/Conversion

    Common Stock, $.001 par value per share

    2011-05-09$13.88/sh+10,000$138,80010,000 total
  • Sale

    Common Stock, $.001 par value per share

    2011-05-09$109.08/sh10,000$1,090,8000 total
  • Exercise/Conversion

    Stock Option (Right to Buy

    2011-05-0910,00026,250 total
    Exercise: $13.88From: 2011-11-01Exp: 2017-11-01Common Stock (10,000 underlying)
Footnotes (2)
  • [F1]These options were granted on November 1, 2007. 25% of the total grant of 75,000 became vested on the first anniversary and 6.25% become vested each quarter thereafter for the following 12 quarters.
  • [F2]Previously filed Forms 4 relating to these options erroneously reported an expiration date of 10/31/2011.

Issuer

Pharmasset Inc

CIK 0001301081

Entity typeother

Related Parties

1
  • filerCIK 0001417894

Filing Metadata

Form type
4
Filed
May 10, 8:00 PM ET
Accepted
May 11, 4:32 PM ET
Size
8.5 KB